Multilayered Control of Protein Turnover by TORC1 and Atg1.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
24 09 2019
Historique:
received: 07 05 2019
revised: 19 07 2019
accepted: 22 08 2019
entrez: 26 9 2019
pubmed: 26 9 2019
medline: 21 10 2020
Statut: ppublish

Résumé

The target of rapamycin complex 1 (TORC1) is a master regulator of cell homeostasis, which promotes anabolic reactions and synchronously inhibits catabolic processes such as autophagy-mediated protein degradation. Its prime autophagy target is Atg13, a subunit of the Atg1 kinase complex that acts as the gatekeeper of canonical autophagy. To study whether the activities of TORC1 and Atg1 are coupled through additional, more intricate control mechanisms than simply this linear pathway, we analyzed the epistatic relationship between TORC1 and Atg1 by using quantitative phosphoproteomics. Our in vivo data, combined with targeted in vitro TORC1 and Atg1 kinase assays, not only uncover numerous TORC1 and Atg1 effectors, but also suggest distinct bi-directional regulatory feedback loops and characterize Atg29 as a commonly regulated downstream target of both TORC1 and Atg1. Thus, an exquisitely multilayered regulatory network appears to coordinate TORC1 and Atg1 activities to robustly tune autophagy in response to nutritional cues.

Identifiants

pubmed: 31553916
pii: S2211-1247(19)31124-6
doi: 10.1016/j.celrep.2019.08.069
pii:
doi:

Substances chimiques

Intracellular Signaling Peptides and Proteins 0
Autophagy-Related Protein-1 Homolog EC 2.7.11.1
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
ULK1 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3486-3496.e6

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Zehan Hu (Z)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Serena Raucci (S)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Malika Jaquenoud (M)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Riko Hatakeyama (R)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Michael Stumpe (M)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Rudolf Rohr (R)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland.

Fulvio Reggiori (F)

Department of Biomedical Sciences of Cells & Systems, University of Groningen, University Medical Center Groningen, 9713 AV Groningen, the Netherlands.

Claudio De Virgilio (C)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland. Electronic address: claudio.devirgilio@unifr.ch.

Jörn Dengjel (J)

Department of Biology, University of Fribourg, 1700 Fribourg, Switzerland. Electronic address: joern.dengjel@unifr.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH